Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lifang Xu

Showing results (31-40 of 32) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 32 results.
Expert Opinion on Biological Therapy|November 7, 2022
Analytical comparability demonstrated for an IgG4 molecule, inclacumab, following transfer of manufacturing responsibility from Roche to Global Blood TherapeuticsRadu Mihaila, Dipali Ruhela, Lifang Xu, et al.
BMC Cancer|November 28, 2025
Echoes of the struggle with cancer: cognitive impairment in Chinese childrenZefang Chen, Ni Zhang, Qian Liu, et al.
Pageof 4

Showing results (31-40 of 32) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 32 results.
Expert Opinion on Biological Therapy|November 7, 2022
Analytical comparability demonstrated for an IgG4 molecule, inclacumab, following transfer of manufacturing responsibility from Roche to Global Blood TherapeuticsRadu Mihaila, Dipali Ruhela, Lifang Xu, et al.
BMC Cancer|November 28, 2025
Echoes of the struggle with cancer: cognitive impairment in Chinese childrenZefang Chen, Ni Zhang, Qian Liu, et al.
Pageof 4